Details of study participants
| Patient No./Age (y)/Sex | WBNAA (mM) | Histology (Grade) | Control | ||
|---|---|---|---|---|---|
| Preoperation | Postoperation | Age (y)/Sex | WBNAA (mM) | ||
| 1/23/F | 12.6 | 13.7 | GGNC-DNT (I) | 25/F | 10.1 |
| 2/30/M | 9.2 | 8.7 | Mixed GN (II) | 30/M | 12.6 |
| 3/32/F | 12.8 | N/A | Mixed GGNC (II) | 31/F | 11.4 |
| 4/32/F | 9.9 | 9.2 | DFA (II) | 30/F | 14.6 |
| 5/32/M | 10.0 | 9.8 | GGNC (II) | 31/M | 11.7 |
| 6/33/F | 7.0 | 8.2 | Mixed GN (II) | 36/F | 12.9 |
| 7/35/M | 10.8 | 11.2 | GBM (IV) | 32/M | 12.4 |
| 8/37/M | 8.6 | 8.5 | Mixed GN (II) | 39/M | 13.2 |
| 9/39/F | 12.2 | 10.9 | Mixed GN (II) | 38/F | 12.7 |
| 10/44/M | 8.2 | 8.4 | Mixed GGNC (II) | 45/M | 13.7 |
| 11/45/M | 9.9 | 8.5 | Anaplastic Mixed GN (III) | 46/M | 14.0 |
| 12/49/F | 9.5 | 10.3 | GBM (IV) | 48/F | 12.5 |
| 13/55/M | 8.5 | 10.6 | Anaplastic mixed GN (III) | 55/M | 13.1 |
| 14/57/M | 7.4 | 6.7 | GBM (IV) | 60/M | 15.1 |
| 15/62/M | 7.9 | 11.2 | AO (III) | 65/M | 11.7 |
| 16/74/M | 7.8 | N/A | GBM (IV) | 75/M | 10.7 |
| 17/79/F | 4.8 | N/A | Anaplastic GGNC (III) | 76/F | 10.7 |
| Avg (mean ± SD) | 9.2 ± 2.1 | 9.7 ± 1.8 | 12.5 ± 1.4 | ||
Note.—N/A indicates biopsy only or insufficient data due to patient movement; GGNC, ganglioglioneurocytoma; DNT, dysembryoplastic neuroepithelial tumor; GN, glioneurocytoma; DFA, diffuse fibrillary astrocytoma; GBM, glioblastoma multiforme; AO, anaplastic oligodendroglioma.